Ejerskov Cecilie, Farholt Stense, Nielsen Flemming Secher Kromann, Berg Ingunn, Thomasen Stine Bogetofte, Udupi Aparna, Ågesen Trude, de Fine Licht Sofie, Handrup Mette Møller
Centre for Rare Diseases, Paediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
Centre for Rare Diseases, Paediatric and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.
Oncol Ther. 2023 Mar;11(1):97-110. doi: 10.1007/s40487-022-00213-4. Epub 2022 Dec 1.
Plexiform neurofibromas (PN) are benign nerve sheath tumours that are a frequent and potentially debilitating complication in patients with neurofibromatosis type 1 (NF1). The objective of this study was to describe the natural history of PN in children, adolescents and adults with NF1.
This was a nationwide, longitudinal cohort study of patients with NF1 under observation at the two national centres of NF1 expertise in Denmark between 2000 and 2020. Patient and clinical characteristics were documented from individual medical records.
A total of 1099 patients with NF1 were included. Overall, 12% (35/296) of paediatric patients and 21% (172/803) of adult patients had ≥ 1 large PN (≥ 3 cm). Approximately half of patients with a large PN had ≥ 1 symptomatic PN. The most frequent symptoms were pain, neurological deficits, cosmetic issues, disfigurement, compression, increased psychosocial burden and vision loss. Clinical evaluations of PN size were available for 40 PN in 34 paediatric patients and 191 PN in 159 adult patients with large PN. Surgery (complete resection or debulking) was performed in 38% (15/40) of PN in paediatric patients and 45% (86/191) in adult patients. In addition, 35% of PN in paediatric patients and 33% in adult patients were inoperable. In a subgroup analysis, the overall PN size increased 1.06-fold per year. Malignant peripheral nerve sheath tumours (MPNST) were diagnosed in 21 patients (two paediatric and 19 adult patients).
This study shows that PN are common, their size and prevalence increase with age, many are often inoperable and pain and other symptoms are frequently associated. The results highlight the severe sequelae and unmet need for alternatives to analgesia and surgery in patients with PN.
丛状神经纤维瘤(PN)是一种良性神经鞘瘤,是1型神经纤维瘤病(NF1)患者常见且可能导致功能障碍的并发症。本研究的目的是描述NF1儿童、青少年和成人患者PN的自然病史。
这是一项在丹麦两个国家NF1专业中心对2000年至2020年期间接受观察的NF1患者进行的全国性纵向队列研究。从个人病历中记录患者和临床特征。
共纳入1099例NF1患者。总体而言,12%(35/296)的儿科患者和21%(172/803)的成年患者有≥1个大PN(≥3 cm)。大约一半有大PN的患者有≥1个有症状的PN。最常见的症状是疼痛、神经功能缺损、美容问题、毁容、压迫、心理社会负担加重和视力丧失。对34例儿科患者的40个PN和159例有大PN的成年患者的191个PN进行了PN大小的临床评估。儿科患者中38%(15/40)的PN和成年患者中45%(86/191)的PN进行了手术(完全切除或减瘤)。此外,儿科患者中35%的PN和成年患者中33%的PN无法手术。在亚组分析中,PN总体大小每年增加1.06倍。21例患者(2例儿科患者和19例成年患者)被诊断为恶性外周神经鞘瘤(MPNST)。
本研究表明,PN很常见,其大小和患病率随年龄增加,许多通常无法手术,且常伴有疼痛和其他症状。结果突出了PN患者严重的后遗症以及对镇痛和手术替代方案的未满足需求。